Allmed Solutions Ltd Asset Resilience Ratio
Allmed Solutions Ltd asset resilience ratio. Allmed Solutions Ltd (ALMD) has an Asset Resilience Ratio of 80.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Allmed Solutions Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Allmed Solutions Ltd (2008–2025)
Asset resilience ratio of Allmed Solutions Ltd from 2008 to 2025. This chart shows how Allmed Solutions Ltd's Asset Resilience Ratio has changed over time. See ALMD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Allmed Solutions Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Allmed Solutions Ltd asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA25.25 Million | 80.03% |
| Total Liquid Assets | ILA25.25 Million | 80.03% |
Asset Resilience Insights
- Very High Liquidity: Allmed Solutions Ltd maintains exceptional liquid asset reserves at 80.03% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Allmed Solutions Ltd Industry Peers by Asset Resilience Ratio
Compare Allmed Solutions Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
GN Store Nord
CO:GN |
Medical Devices | -4.56% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
Allmed Solutions Ltd Asset Resilience Ratio by Year (2008–2025)
Allmed Solutions Ltd asset resilience ratio by year from 2008 to 2025. The table below shows the annual Asset Resilience Ratio data for Allmed Solutions Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 80.03% | ILA25.25 Million ≈ $67.68K |
ILA31.54 Million ≈ $84.57K |
-7.63pp |
| 2024-12-31 | 87.66% | ILA39.27 Million ≈ $105.27K |
ILA44.79 Million ≈ $120.09K |
+2.44pp |
| 2023-12-31 | 85.22% | ILA50.43 Million ≈ $135.19K |
ILA59.17 Million ≈ $158.63K |
+77.27pp |
| 2019-12-31 | 7.96% | ILA5.35 Million ≈ $14.34K |
ILA67.20 Million ≈ $180.17K |
-12.94pp |
| 2018-12-31 | 20.89% | ILA9.00 Million ≈ $24.14K |
ILA43.09 Million ≈ $115.52K |
-8.06pp |
| 2017-12-31 | 28.95% | ILA15.01 Million ≈ $40.24K |
ILA51.85 Million ≈ $139.02K |
+7.87pp |
| 2016-12-31 | 21.08% | ILA11.01 Million ≈ $29.51K |
ILA52.22 Million ≈ $140.00K |
-15.81pp |
| 2015-12-31 | 36.88% | ILA21.01 Million ≈ $56.32K |
ILA56.95 Million ≈ $152.69K |
+28.78pp |
| 2012-12-31 | 8.10% | ILA6.52 Million ≈ $17.49K |
ILA80.52 Million ≈ $215.88K |
+7.76pp |
| 2011-12-31 | 0.34% | ILA270.00K ≈ $723.86 |
ILA79.55 Million ≈ $213.28K |
-20.63pp |
| 2008-12-31 | 20.96% | ILA3.25 Million ≈ $8.70K |
ILA15.48 Million ≈ $41.51K |
-- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more